Passage Bio, Inc.
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene …
Biotechnology
US, Philadelphia [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Passage Bio, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDPassage Bio, Inc. can't present revenue by segment